The Harvard Campaign, officially launched on September 21 after the quietest of quiet phases, seeks $6.5 billion—the largest initial target ever set in American higher education—and begins its public phase with $2.8 billion already received or pledged. Peter Sorger, the Krayer professor of systems pharmacology at HMS and head of the Harvard Program in Therapeutic Science, is quoted.
